With the threat of a recession looming on the economic horizon coupled with foreboding predictions of funding drops for life sciences companies, emerging geographic markets across the country are in some cases better-positioned than their more established counterparts to weather the pending storm.
Downturns can be particularly dangerous for emerging markets, especially in life sciences, where there’s particularly high risk and long-term investment in larger developments. In late April, Alexandria Real Estate Equities Chairman Joel Marcus talked about a coming “have and have-not” era of biotech favoring established firms and markets.
But the lower barriers to entry and growing talent pools in smaller markets may help insulate them from coming turmoil, especially those that have managed to attract major development players.
Read the full article at: www.bisnow.com
